Potential biomarker for aspirin use in colorectal cancer therapy. by Langley, R, Rothwell, P

Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy by Langley, R, Rothwell, P

Probabilistic assessment of performance under uncertain information using a generalised maximum entropy principle by Cicirello, A, Langley, R

The effect of generalized force correlations on the response statistics of a harmonically driven random system by Langley, R, Cicirello, A, Deckers, E

Bistate frequency selective surfaces made of intertwined slot arrays by Vallecchi, A, Langley, R, Schuchinsky, A

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. by Seymour, M, Thompson, L, Wasan, H, Middleton, G, Brewster, A, Shepherd, S, O'Mahony, MS, Maughan, T, Parmar, M, Langley, R

Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2) by Seymour, M, Maughan, T, Wasan, H, Brewster, A, Shepherd, SE, O'Mahoney, MS, May, B, Thompson, L, Meade, A, Langley, R, Studies, U

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols by Schiavone, F, Bathia, R, Letchemanan, K, Masters, L, Amos, C, Bara, A, Brown, L, Gilson, C, Pugh, C, Atako, N, Hudson, F, Parmar, M, Langley, R, Kaplan, RS, Parker, C, Attard, G, Clarke, NW, Gillessen, S, James, ND, Maughan, T, Sydes, MR, The Stampede And Focus4 Trial Management Group

A community approach to mortality prediction in sepsis via gene expression analysis by Sweeney, T, Perumal, T, Henao, R, Nichols, M, Howrylak, J, Choi, A, Bermejo-Martin, J, Almansa, R, Tamayo, E, Davenport, E, Burnham, K, Hinds, C, Knight, J, Woods, C, Kingsmore, S, Ginsburg, G, Wong, H, Parnell, G, Tang, B, Moldawer, L, Moore, F, Omberg, L, Khatri, P, Tsalik, E, Mangravite, L, Langley, R

Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis by Wang, L, Ko, E, Gilchrist, J, Pittman, K, Rautanen, A, Pirinen, M, Thompson, J, Dubois, L, Langley, R, Jaslow, S, Salinas, R, Rouse, D, Moseley, M, Mwarumba, S, Njuguna, P, Mturi, N, Wellcome Trust Case Control Consortium 2, Kenyan Bacteraemia Study Group, Williams, T, Scott, J, Hill, A, Woods, C, Ginsburg, G, Tsalik, E, Ko, D